Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee, Ariane Sternberg, Ulrike Stange, Stefan Laufer, Cord Naujokat
Topics & Concepts
FavipiravirLopinavirTMPRSS2VirologyRitonavirCoronavirusChloroquineVirusPandemicAntiviral drugPharmacologyMedicineBiologyCoronavirus disease 2019 (COVID-19)ImmunologyViral loadDiseaseMalariaInfectious disease (medical specialty)PathologyAntiretroviral therapySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDrug-Induced Hepatotoxicity and Protection